Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States

Autor:	Rohini K. Hernandez, Yi Qian, Debajyoti Bhowmik, Christopher Bond, Steven Wang, Sam Colman, M. Intorcia, Paul Cheng
Rok vydání:	2017
Předmět:	renal impairment Male Nephrology intravenous bisphosphonate Cancer Research medicine.medical_specialty nephrotoxic agent Population Renal function Antineoplastic Agents Kaplan-Meier Estimate Kidney Function Tests Nephrotoxicity 03 medical and health sciences 0302 clinical medicine Chronic kidney disease Internal medicine Antineoplastic Combined Chemotherapy Protocols Prevalence medicine Humans Radiology Nuclear Medicine and imaging Renal Insufficiency Practice Patterns Physicians' Renal Insufficiency Chronic Intensive care medicine education Multiple myeloma Original Research Retrospective Studies education.field_of_study business.industry Clinical Cancer Research Retrospective cohort study medicine.disease United States multiple myeloma Oncology 030220 oncology & carcinogenesis Female Kidney Diseases business Complication Glomerular Filtration Rate 030215 immunology Kidney disease
Zdroj:	Cancer Medicine
ISSN:	2045-7634
DOI:	10.1002/cam4.1075
Popis:	Renal impairment is a common complication of multiple myeloma and deterioration in renal function or renal failure may complicate clinical management. This retrospective study in patients with multiple myeloma using an electronic medical records database was designed to estimate the prevalence of renal impairment (single occurrence of estimated glomerular filtration rate [eGFR]
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ed90da177e39b49ff56c20f3ce6528 https://doi.org/10.1002/cam4.1075 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.